444249
基质金属蛋白酶MMP-2/MMP-9抑制剂II
The MMP-2/MMP-9 Inhibitor II, also referenced under CAS 193807-60-2, controls the biological activity of MMP-2/MMP-9. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
别名:
基质金属蛋白酶MMP-2/MMP-9抑制剂II, （2R）-[（4-联苯磺酰基）氨基]-N-羟基-3-苯基丙酰胺，BiPS，BiPS
登录查看公司和协议定价
所有图片(1)
About This Item
推荐产品
质量水平
方案
≥95% (HPLC)
表单
solid
制造商/商品名称
Calbiochem®
储存条件
OK to freeze
颜色
off-white
溶解性
DMSO: 100 mg/mL
methanol: 25 mg/mL
运输
ambient
储存温度
−20°C
一般描述
IV型胶原酶的有效抑制剂，MMP-2（IC50=17 nM）和MMP-9（IC50=30 nM）。还显示出可以有效诱导并快速激活HIF。已显示在鼠模型中体内抑制Lewis肺癌诱导的肺定植。
MMP-2（IC50=17 nM）和MMP-9（IC50=30 nM）的有效抑制剂。还显示出可以有效诱导并快速激活HIF。据报告在鼠模型中抑制Lewis肺癌诱导的肺定植。
生化/生理作用
主要靶标
MMP-2
MMP-2
产物不与ATP竞争。
可逆：否
细胞渗透性：否
靶标IC50：MMP-2和MMP-9分别为17 nM和30 nM
包装
用惰性气体包装
警告
毒性：标准处理（A）
重悬
复溶后，等分并冷冻保存（-20°C）。贮备液在-20°C下可稳定保存至多6个月。
其他说明
Lauzier, M.C., et al. 2008.Mol.Pharmacol.In press.
Mifune, M., et al. 2005.J. Biol. Chem.280, 26592.
Zhang, H., et al. 2004.Circ.Res.95, 989.
Tamura, Y., et al. 1998.J. Med. Chem.41, 640.
Mifune, M., et al. 2005.J. Biol. Chem.280, 26592.
Zhang, H., et al. 2004.Circ.Res.95, 989.
Tamura, Y., et al. 1998.J. Med. Chem.41, 640.
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
储存分类代码
11 - Combustible Solids
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Shin Matsubara et al.
Bio-protocol, 10(7), e3577-e3577 (2021-03-05)
Ascidians are the closest living relatives of vertebrates ( Delsuc et al., 2006 ; Satoh et al., 2014 ) and are important for the evolutionary study of the ovarian follicle development including oocyte maturation and ovulation. However, neither the endogenous
E Kamanga-Sollo et al.
Domestic animal endocrinology, 58, 90-96 (2016-10-22)
In feedlot steers, estradiol-17β (E2) and combined E2 and trenbolone acetate (a testosterone analog) implants enhance rate and efficiency of muscle growth; and, consequently, these compounds are widely used as growth promoters in several countries. Treatment with E2 stimulates protein
Mehdi Benlarbi et al.
iScience, 25(11), 105316-105316 (2022-10-19)
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike glycoprotein (S) binds to angiotensin-converting enzyme 2 (ACE2) to mediate membrane fusion via two distinct pathways: 1) a surface, serine protease-dependent or 2) an endosomal, cysteine protease-dependent pathway. In this study, we found
相关内容
Select different protease inhibitor types based on your needs to prevent protein degradation during isolation and characterization and safeguard proteins in sample prep.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门